Clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/483572/2012
Published09/08/2012
Effective from01/09/2012
KeywordsChronic obstructive pulmonary disease (COPD), airflow obstruction, relief of symptoms, maintenance treatment
DescriptionThis document provides guidance for the clinical evaluation of new medicinal products for the treatment of chronic obstructive pulmonary disease (COPD). It specifically focuses on the maintenance treatment of COPD.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/09/2012–present


Published: 22/11/2012


Published: 20/09/2010


Published: 19/0/2009

Superseded documentPoints to considerPubished: 19/05/1999


Related content


How helpful is this page?

Average rating:

 Based on 2 ratings

Add your rating:

See all ratings
1 ratings
0 ratings
0 ratings
1 ratings
0 ratings
    

Tell us more